✦ LIBER ✦

PMH4 A SYSTEMATIC REVIEW OF THE REAL-WORLD STUDY EVIDENCE COMPARING THE SAFETY AND TOLERABILITY OF DONEPEZIL, RIVASTIGMINE AND GALANTAMINE FOR THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE

✍ Scribed by I Lockhart; S Mitchell; S Kelly

Book ID: 118612315
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 98 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)74723-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Donepezil, Galant

Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

✍ Tan, Chen-Chen ;Yu, Jin-Tai ;Wang, Hui-Fu ;Tan, Meng-Shan ;Meng, Xiang-Fei ;Wang 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 792 KB

Efficacy and Safety of Donepezil, Galant

Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

✍ Tan, Chen-Chen ;Yu, Jin-Tai ;Wang, Hui-Fu ;Tan, Meng-Shan ;Meng, Xiang-Fei ;Wang 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 792 KB

P1-385 A head study of donepezil, rivast

P1-385 A head study of donepezil, rivastigmine, and galantamine for the treatment of Alzheimer's disease: safety, tolerability, clinical and caregiver impressions after 9 months of treatment

✍ Joshua R. Shua-Haim; Mark D. Pass; Suhas Patel; Sameer Patel; Paul Lee; Pritesh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 155 KB

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati

First head to head study comparing the t

First head to head study comparing the tolerability and satisfaction/ease of use of donepezil and galantamine in Alzheimer's disease

✍ D. Aarsland; K. Alhainen; R. Bullock; P. Wetterberg; R. Smith; H. Soininen; A. M 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Open label, multicenter, 28-week extensi

Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

✍ Brian R. Ott; Lesley M. Blake; Ethel Kagan; Malca Resnick; for the Memantine MEM 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB